Xcout IntelGreenMark Biomedical Inc.
GreenMark Biomedical Inc. is a biotechnology research and healthcare company located in East Lansing, Michigan, that develops technologies to enable dentists to preserve tooth structure by detecting and treating dental caries.
Subscribe to see GreenMark Biomedical Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
GreenMark Biomedical Inc. at a glance
GreenMark Biomedical Inc. is a biotechnology & dental products company headquartered in United States. Its most recent funding round raised $5M in April 2026. Xcout tracks 10 named people at GreenMark Biomedical Inc., including Steven Bloembergen (Chairman and CEO).
GreenMark Biomedical Inc. leadership
- Steven BloembergenChairman and CEO
- Steven BloembergenFounder, Chairman and CEO
- Steven BloembergenExecutive Officer
- Frank van LuttikhuizenDirector
- Jeff WesleyDirector
- Joerg Lahann, Ph.D.Director
4 more named people on record for GreenMark Biomedical Inc., with roles, board committees and tenure — see the full roster →
GreenMark Biomedical Inc. funding rounds
The 6 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $5M | — | |
| Grant | Undisclosed | — | |
| SEC Form D filing | $500,000 | — | |
| SEC Form D filing | $500,000 | — | |
| — | $2M | — | |
| Seed | $500,000 | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
GreenMark Biomedical Inc. competitors
A few of GreenMark Biomedical Inc.'s closest competitors — see the full list of competitors and alternatives →
Micron Biomedical, Inc. is a clinical-stage biopharmaceutical and life science company committed to expanding global access to therapeutics and vaccines formulated into proprietary array-based delivery technologies.
Eterna Regeneratives develops regenerative biomaterials and protein-derived scaffolds designed for mineralisation and tissue regeneration. The company's initial applications focus on oral health and enamel repair through professional consumer dental care formats, as well as bone regeneration for orthopaedic and bone grafting uses.
Iotech International develops and markets molecular iodine-based health and hygiene products, primarily focusing on oral care solutions such as mouthwashes, rinses, gels, and nutritional supplements. The company serves individual consumers as well as dental and medical professionals seeking clinical-grade formulations for oral hygiene and related health needs.
NuShores Biosciences LLC develops patented bone and tissue regeneration technologies, specifically focusing on its NuCress scaffold product line to heal large segmental bone defects. The company serves medical and veterinary markets by providing advanced solutions for complex bone injuries in cranio-maxillofacial, dental, limb, and spinal applications.
Get GreenMark Biomedical Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on GreenMark Biomedical Inc. in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 7 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access